160 related articles for article (PubMed ID: 24636378)
21. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
22. Social preferences for health states associated with acute myeloid leukemia for patients undergoing treatment in the United Kingdom.
Castejón N; Cappelleri JC; Cuervo J; Lang K; Mehta P; Mokgokong R; Mamolo C
Health Qual Life Outcomes; 2018 Apr; 16(1):66. PubMed ID: 29669568
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Survival After Traumatic Brain Injury Part II: Life Expectancy.
Brooks JC; Shavelle RM; Strauss DJ; Hammond FM; Harrison-Felix CL
Arch Phys Med Rehabil; 2015 Jun; 96(6):1000-5. PubMed ID: 26043195
[TBL] [Abstract][Full Text] [Related]
24. Outcomes and quality of care in acute myeloid leukemia over 40 years.
Alibhai SM; Leach M; Minden MD; Brandwein J
Cancer; 2009 Jul; 115(13):2903-11. PubMed ID: 19452536
[TBL] [Abstract][Full Text] [Related]
25. The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands.
Leunis A; Blommestein HM; Huijgens PC; Blijlevens NM; Jongen-Lavrencic M; Uyl-de Groot CA
Leuk Res; 2013 Mar; 37(3):245-50. PubMed ID: 23069745
[TBL] [Abstract][Full Text] [Related]
26. Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-naïve and -experienced United Kingdom patients in 2011.
Simpson KN; Baran RW; Collomb D; Beck EJ; Van de Steen O; Dietz B
J Med Econ; 2012; 15(4):796-806. PubMed ID: 22563716
[TBL] [Abstract][Full Text] [Related]
27. Acute myeloid leukaemia in Western Australia 1991-2005: a retrospective population-based study of 898 patients regarding epidemiology, cytogenetics, treatment and outcome.
Gangatharan SA; Grove CS; P'ng S; O'Reilly J; Joske D; Leahy MF; Threlfall T; Wright MP
Intern Med J; 2013 Aug; 43(8):903-11. PubMed ID: 23611681
[TBL] [Abstract][Full Text] [Related]
28. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
30. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
Nelson CL; Sun JL; Tsiatis AA; Mark DB
Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
[TBL] [Abstract][Full Text] [Related]
31. Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach.
Mau LW; Preussler JM; Burns LJ; Leppke S; Majhail NS; Meyer CL; Mupfudze T; Saber W; Steinert P; Vanness DJ
Pharmacoeconomics; 2020 May; 38(5):515-526. PubMed ID: 32128725
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy.
Pham AN; Datta SK; Weber TJ; Walter LC; Colón-Emeric CS
J Am Geriatr Soc; 2011 Sep; 59(9):1642-9. PubMed ID: 21883116
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype.
Hörster L; Schlenk RF; Stadler M; Gabriel M; Thol F; Schildmann J; Vollmann J; Rochau U; Sroczynski G; Wasem J; Ganser A; Port M; Neumann A
Leuk Res; 2017 Nov; 62():84-90. PubMed ID: 28988037
[TBL] [Abstract][Full Text] [Related]
34. Optimal management of high-risk T1G3 bladder cancer: a decision analysis.
Kulkarni GS; Finelli A; Fleshner NE; Jewett MA; Lopushinsky SR; Alibhai SM
PLoS Med; 2007 Sep; 4(9):e284. PubMed ID: 17896857
[TBL] [Abstract][Full Text] [Related]
35. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model.
Hogendoorn W; Hunink MG; Schlösser FJ; Moll FL; Muhs BE; Sumpio BE
J Vasc Surg; 2014 Sep; 60(3):715-25.e2. PubMed ID: 24721175
[TBL] [Abstract][Full Text] [Related]
36. Economic burden associated with acute myeloid leukemia treatment.
Zeidan AM; Mahmoud D; Kucmin-Bemelmans IT; Alleman CJ; Hensen M; Skikne B; Smith BD
Expert Rev Hematol; 2016 Jan; 9(1):79-89. PubMed ID: 26568358
[TBL] [Abstract][Full Text] [Related]
37. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.
Chang RW; Pellisier JM; Hazen GB
JAMA; 1996 Mar; 275(11):858-65. PubMed ID: 8596224
[TBL] [Abstract][Full Text] [Related]
38. Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010.
Pulte D; Gondos A; Brenner H
Ann Oncol; 2010 Feb; 21(2):335-341. PubMed ID: 19633049
[TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
[TBL] [Abstract][Full Text] [Related]
40. Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.
Pfirrmann M; Ehninger G; Thiede C; Bornhäuser M; Kramer M; Röllig C; Hasford J; Schaich M;
Lancet Oncol; 2012 Feb; 13(2):207-14. PubMed ID: 22197676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
